Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
Year-over-year revenue growth rate
5Y CAGR
-18.3%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 29.53% |
| Q4 2025 | -65.33% |
| Q2 2025 | 243.47% |
| Q1 2025 | -41.91% |
| Q4 2024 | 69.32% |
| Q3 2024 | -40.59% |
| Q2 2024 | 88.50% |
| Q1 2024 | -63.18% |
| Q4 2023 | 125.03% |
| Q3 2023 | -23.46% |
| Q2 2023 | 44.35% |
| Q1 2023 | -14.07% |
| Q4 2022 | -4.93% |
| Q3 2022 | 19.42% |
| Q2 2022 | -5.73% |
| Q1 2022 | -67.75% |
| Q4 2021 | 230.60% |
| Q3 2021 | 5.84% |
| Q2 2021 | 12.67% |
| Q1 2021 | -61.55% |
| Q4 2020 | 81.34% |
| Q3 2020 | 9.99% |
| Q2 2020 | 9.13% |
| Q1 2020 | -72.99% |
| Q4 2019 | 194.05% |
| Q3 2019 | 2.49% |
| Q2 2019 | -44.88% |
| Q1 2019 | 54.71% |
| Q4 2018 | 32.13% |
| Q3 2018 | 23.48% |
| Q2 2018 | -18.47% |
| Q1 2018 | -16.18% |
| Q4 2017 | 45.63% |
| Q3 2017 | 5.38% |
| Q2 2017 | -3.05% |
| Q1 2017 | -27.78% |
| Q4 2016 | 44.55% |
| Q3 2016 | 188.35% |
| Q2 2016 | 4.33% |
| Q1 2016 | -28.50% |